Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Validation of the Prognosis of Patients with ER‑positive, HER2‑negative and Node‑negative Invasive Breast Cancer Classified As Low Risk by Curebest™ 95GC Breast in a Multi‑institutional Registry Study.

Yasuto Naoi,Ryo Tsunashima,Kenzo Shimazu,Masahiro Oikawa,Seiichi Imanishi,Hiroshi Koyama,Yoshihiko Kamada,Kazuhiro Ishihara,Masahiko Suzuki,Tomo Osako,Takayuki Kinoshita,Akihiko Suto,Seigo Nakamura,Hitoshi Tsuda,Shinzaburo Noguchi

Oncology Letters（2023）

Cited 2|Views39
Key words
Curebest 95GC breast,breast cancer,prognosis,registry study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined